- Home
- AVIR vs RLTY Comparison
AVIR vs RLTY Comparison
Compare AVIR & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | RLTY |
|---|---|---|
| Founded | 2012 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.9M | 245.8M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AVIR | RLTY |
|---|---|---|
| Price | $5.32 | $14.59 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 583.3K | 54.4K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.35% |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $12.90 |
| 52 Week High | $6.45 | $15.97 |
Technical Indicators
Market Signals| Indicator | AVIR | RLTY |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 39.50 |
| Support Level | $3.28 | $14.45 |
| Resistance Level | $6.45 | $15.39 |
| Average True Range (ATR) | 0.26 | 0.26 |
| MACD | -0.14 | -0.08 |
| Stochastic Oscillator | 28.88 | 31.45 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.